Modeling Alzheimer's disease with iPSC-derived brain cells
Alzheimer's disease is a devastating neurodegenerative disorder with no cure. Countless
promising therapeutics have shown efficacy in rodent Alzheimer's disease models yet failed …
promising therapeutics have shown efficacy in rodent Alzheimer's disease models yet failed …
Current challenges of iPSC-based disease modeling and therapeutic implications
Induced pluripotent stem cell (iPSC)-based disease modelling and the cell replacement
therapy approach have proven to be very powerful and instrumental in biomedical research …
therapy approach have proven to be very powerful and instrumental in biomedical research …
Cell therapies in the clinic
Cell therapies have emerged as a promising therapeutic modality with the potential to treat
and even cure a diverse array of diseases. Cell therapies offer unique clinical and …
and even cure a diverse array of diseases. Cell therapies offer unique clinical and …
Neural stem cell transplantation for neurodegenerative diseases
R De Gioia, F Biella, G Citterio, F Rizzo, E Abati… - International journal of …, 2020 - mdpi.com
Neurodegenerative diseases are disabling and fatal neurological disorders that currently
lack effective treatment. Neural stem cell (NSC) transplantation has been studied as a …
lack effective treatment. Neural stem cell (NSC) transplantation has been studied as a …
Human iPSC banking: barriers and opportunities
CY Huang, CL Liu, CY Ting, YT Chiu… - Journal of biomedical …, 2019 - Springer
The introduction of induced pluripotent stem cells (iPSCs) has opened up the potential for
personalized cell therapies and ushered in new opportunities for regenerative medicine …
personalized cell therapies and ushered in new opportunities for regenerative medicine …
Autologous induced pluripotent stem cell–based cell therapies: Promise, progress, and challenges
The promise of human induced pluripotent stem cells (iPSCs) lies in their ability to serve as
a starting material for autologous, or patient‐specific, stem cell–based therapies. Since the …
a starting material for autologous, or patient‐specific, stem cell–based therapies. Since the …
[HTML][HTML] Tumorigenicity assessment of cell therapy products: The need for global consensus and points to consider
Y Sato, H Bando, M Di Piazza, G Gowing, C Herberts… - Cytotherapy, 2019 - Elsevier
Pluripotent stem cells offer the potential for an unlimited source for cell therapy products.
However, there is concern regarding the tumorigenicity of these products in humans, mainly …
However, there is concern regarding the tumorigenicity of these products in humans, mainly …
Cell culture‐derived extracellular vesicles: Considerations for reporting cell culturing parameters
Cell culture‐conditioned medium (CCM) is a valuable source of extracellular vesicles (EVs)
for basic scientific, therapeutic and diagnostic applications. Cell culturing parameters affect …
for basic scientific, therapeutic and diagnostic applications. Cell culturing parameters affect …
Characterization of stem-cell-derived islets during differentiation and after implantation
Recapitulation of embryonic pancreatic development has enabled development of methods
for in vitro islet cell differentiation using human pluripotent stem cells (hPSCs), which have …
for in vitro islet cell differentiation using human pluripotent stem cells (hPSCs), which have …
Engineering considerations of iPSC-based personalized medicine
Personalized medicine aims to provide tailored medical treatment that considers the clinical,
genetic, and environmental characteristics of patients. iPSCs have attracted considerable …
genetic, and environmental characteristics of patients. iPSCs have attracted considerable …